Cheaper Alternatives to Wegovy and Zepbound

The cheapest alternatives to Wegovy and Zepbound are usually the same medicines bought a different way. You can use manufacturer self-pay: the Wegovy pill starts at $149 a month and the Zepbound KwikPen starts at $299 a month. Or you can use compounded semaglutide or tirzepatide, which had median prices of about $170 and $239 a month in an August 2026 index of telehealth providers. Compare the price at the dose you will stay on, because most starter prices go up as your dose rises. An older GLP-1 such as Saxenda (liraglutide) is not a cheaper swap. It lost far less weight than semaglutide in a head-to-head trial, and it lists at $1,349 a month.

What is the cheapest way to get semaglutide or tirzepatide without insurance?

Compounded semaglutide usually costs the least. If you want the brand name, the Wegovy pill has the lowest self-pay starting price. Brand list prices are the most you would pay, and the manufacturers' self-pay programs cost less: Wegovy lists at about $1,349 a month and Zepbound at about $1,086 a month.

Why does the price go up after the first month?

Your dose climbs, and the price climbs with it. Zepbound starts at 2.5 mg. After at least 4 weeks, your prescriber may raise it in 2.5 mg steps until you reach a maintenance dose. Lilly says 2.5 mg is a starting dose and is not approved as a maintenance dose, so the $299 starting price is not what you will pay for the long haul.

Wegovy works the same way. The pen's $199 price covers only the first two fills of the lowest doses. After that, the self-pay price is $349 a month, or $399 for the 7.2 mg dose.

Compounded prices can rise too. The index lists introductory or first-month rates where a provider runs a promo, and it notes that ongoing rates are typically higher.

Before you choose, ask for the monthly price at the dose you expect to stay on. Compare that number, not the starter price.

Does compounded semaglutide work as well as Wegovy?

It came close in the one direct comparison we found. In an Australian online weight-loss program, people on compounded semaglutide lost 9.11% of their body weight after about four months, compared with 9.87% on brand. Both groups followed the same dosing schedule. The difference was statistically significant but small.

The gap showed up at the bigger milestones. About the same share of people in each group reached 5% weight loss. More people on brand reached 10% (50.54% vs 44.64%) and 15% (21.42% vs 12.78%). Slightly fewer people on compounded semaglutide reported any side effect (71.61% vs 77.40%), and the whole difference was in mild side effects.

That result came from compounded semaglutide made under Pharmacy Board of Australia guidelines and tested every month at an independent University of Sydney lab. The authors say compounding can vary from pharmacy to pharmacy, so their result does not apply to every compounded product.

Pharmacies differ in how they check quality. Some publish a certificate of analysis (a lab report on the batch) for every batch, and others will not share one at all. Ask your clinical team which pharmacy makes yours and how it is tested.

For one poster, the quieter appetite was the big change. In r/tirzepatidecompound, in a thread about losing weight on compounded tirzepatide at 69, they described it this way: "The reduction in hunger, and especially the urge to overeat, made doing everything else much easier."

Our clinical team can prescribe semaglutide or tirzepatide if either fits your goal.

Is an older GLP-1 like Saxenda a cheaper option?

No. In the 68-week STEP 8 head-to-head trial, 78.4% of the 338 adults were women, and their average age was 49. People on weekly semaglutide injections lost an average of 15.8% of their body weight. People on daily liraglutide (the medicine in Saxenda) lost 6.4%.

More people stayed on semaglutide. Treatment was stopped for any reason by 13.5% of people on semaglutide and 27.6% of people on liraglutide. Liraglutide is also a daily shot, while semaglutide is a weekly one.

Saxenda is not cheaper at list, either. It lists at about $1,349 a month, the same as Wegovy.

Which cheaper option fits me?

• If needles put you off: look at the Wegovy pill. It is a semaglutide tablet, and like the Wegovy shot, it is labeled for adults with obesity, or adults with excess weight and weight-related health problems. The label says to use it with a reduced-calorie diet and more physical activity to lose weight and keep it off.
• What a semaglutide pill can do: in the 68-week OASIS 1 trial, a 50 mg daily dose led to 15.1% weight loss, compared with 2.4% on placebo. Stomach side effects were reported by 80% of people on the pill and 46% on placebo. That trial dose is higher than the Wegovy pill doses sold now (1.5 mg to 25 mg), so do not expect the same result. Ask your clinical team what to expect at your dose.
• If the lowest monthly cost matters most: compounded semaglutide or tirzepatide usually costs the least. Quality depends on the pharmacy, so ask how yours is made and tested.
• If you want the brand name and have insurance that may cover it: check the $25 savings offers first. If you are paying yourself, compare self-pay brand prices at your maintenance dose with compounded prices.
• Whatever you choose, share your health history: tell your clinical team about it before you start. The Wegovy label says not to use it if you or anyone in your family has had medullary thyroid carcinoma (a type of thyroid cancer), or if you have MEN 2 (an inherited gland condition). The label also says to stop Wegovy 2 months before you plan to get pregnant.
• If side effects get worse: tell your clinical team early. A medicine that makes you feel awful is the wrong fit at any price.

Take the quiz so your clinical team can see whether semaglutide or tirzepatide fits your goal, your budget and how you feel about needles.